Physician profile
Kenneth Ring
NPI 1225025174
$5,207.12
in general payments reported to CMS, 2019-2025
40 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $344 · 2021: $952 · 2022: $658 · 2023: $734 · 2024: $702 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,394.21 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $787.57 | 2019-2022 | |
| Janssen Biotech, INC. | $629.74 | 2022-2025 | Erleada, Rybrevant, Carvykti |
| Teleflex LLC | $572.62 | 2021-2025 | Urolift, Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $429.24 | 2019-2025 | |
| Olympus America INC. | $238.18 | 2025 | Itind System |
| Axonics, INC. | $207.28 | 2021-2023 | Axonics, Bulkamid |
| Antares Pharma, INC. | $200.81 | 2021-2024 | Xyosted |
| Pfizer INC. | $184.34 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $157.09 | 2021-2023 | Xiaflex |
| Medtronic, INC. | $152.95 | 2022-2024 | Interstim |
| Dendreon Pharmaceuticals LLC | $142.21 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $136.61 | 2023-2024 | Gemtesa |
| Myovant Sciences INC. | $126.02 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $107.39 | 2021-2025 | Trelstar |
| Urogen Pharma, INC. | $101.05 | 2023-2025 | Jelmyto |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.